Early Phase 1
N=124
Boost Study 21270 (Cognition)
Cognitive Function Abnormal
Bottom Line
View on ClinicalTrials.gov: NCT05990335 ↗Enrolled (actual)
124
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcome: Primary: Task Completion Rate — 66; 57 Percentage of eligible participants
Study Design & Population
- Study type
- Interventional
- Phase
- Early Phase 1
- Interventions
- mHealth application (custom) (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- NXTech
- Primary completion
- Mar 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Task Completion Rate |
66; 57 | — |
| SECONDARY Change in Task Performance |
0.62; 0.62 | — |
Summary
This study is designed to to test the technical feasibility of encouraging interaction with a mobile smartphone software package (mHealth app) for training aspects of executive function and cognition.
Eligibility Criteria
Inclusion Criteria
- Age 18 years and above
- Fluent in English
- Resides in the United States
- Score on prescreen task is in 25% quartile
- Familiar with smartphone device app installation and device usage
- Possesses a compatible smartphone
Exclusion Criteria
None
Data sourced from ClinicalTrials.gov (NCT05990335). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.